Results 171 to 180 of about 939 (187)

Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine (1616)

Neurology, 2021
Jelena M. Pavlovic, Jessica Ailani, Susan Hutchinson, Hongxin Lai, Brett Dabruzzo, Sung Yun Yu, Joel M. Trugman, E. Anne MacGregor   +7 more
openaire   +1 more source

Comparative Efficacy and Safety of Rimegepant, Ubrogepant, and Lasmiditan for Acute Treatment of Migraine: A Network Meta-Analysis

Expert Review of Pharmacoeconomics and Outcomes Research, 2022
Karissa M. Johnston, Robert Croop, Linda Harris   +2 more
exaly  

Efficacy of Ubrogepant in a Preclinical Model of Medication Overuse Headache (1148)

Neurology, 2020
Edita Navratilova, Janice Oyarzo, David W. Dodick, Pradeep Banerjee, Frank Porreca   +4 more
openaire   +1 more source

Ubrogepant: An Oral Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist for Abortive Migraine Treatment

Annals of Pharmacotherapy, 2022
Madell Nedd, Scott Garland, Ashley Wilk
exaly  

Ubrogepant is Effective in the Acute Treatment of Migraine with Mild Pain (4726)

Neurology, 2020
Richard Lipton, David Dodick, Peter Goadsby, Rami Burstein, Aubrey Adams, Jeff Lai, Sung Yu, Michelle Finnegan, Joel Trugman   +8 more
openaire   +1 more source

A Phase IIb Randomized, Double-Blind, Placebo-Controlled Trial of Ubrogepant for the Acute Treatment of Migraine

Cephalalgia, 2016
David W Dodick, Richard B. Lipton, David Michelson   +2 more
exaly  

Pain Freedom at 2‐8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant: A Response

Headache: The Journal of Head and Face Pain, 2020
Gilbert J, L'Italien, Robert, Croop, David A, Stock   +2 more
openaire   +2 more sources

FDA Approves Ubrogepant for Acute Treatment of Migraine

Neurology Today, 2020
openaire   +1 more source

BIOCATALYST AND METHOD FOR THE SYNTHESIS OF UBROGEPANT INTERMEDIATES

2023
CHEN HAIBIN, HU HU, CAI BAOQIN, XU JUNPENG, LIU SITONG, JIN LUPING, WU XINWEI, CUI QINYAN, ZHANG CHENGXIAO, ZHU KAILONG   +9 more
openaire   +1 more source

Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication (533)

Neurology, 2020
Andrew M. Blumenfeld, Kerry Knievel, Aubrey Manack Adams, Lawrence Severt, Matthew Butler, Hongxin Lai, David W. Dodick   +6 more
openaire   +1 more source